Clinical Trials

Recently, INSYS Therapeutics, Inc. INSY , a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, recently initiated a Phase 2 clinical trial of its cannabidiol (CBD) oral solution for evaluation of safety and efficacy in pediatric patients with Prader-Willi syndrome, a rare genetic disease characterized by insatiable appetite in children that […]

COLUMBUS (WCMH) – Children and adults with a severe and complex form of epilepsy called Lennox-Gastaut Syndrome can have hundreds of seizures each day.  A cannabis-derived treatment studied at Nationwide Children’s Hospital is showing impressive results in reducing those seizures, bringing hope to families. It’s a part of an international study, with 30 centers participating in […]

THURSDAY, May 17, 2018 — Less appears to be more when it comes to treating epilepsy with the marijuana extract cannabidiol, a new clinical trial suggests. Patients taking a 10-milligram daily dose of pharmaceutical grade cannabidiol, or CBD, experienced nearly as great a reduction in seizures as patients on 20 mg, and with fewer side […]

COLUMBUS (WCMH) – Children and adults with a severe and complex form of epilepsy called Lennox-Gastaut Syndrome can have hundreds of seizures each day.  A cannabis-derived treatment studied at Nationwide Children’s Hospital is showing impressive results in reducing those seizures, bringing hope to families. It’s a part of an international study, with 30 centers participating in […]

By Dennis Thompson HealthDay Reporter WEDNESDAY, May 16, 2018 (HealthDay News) — Less appears to be more when it comes to treating epilepsy with the marijuana extract cannabidiol, a new clinical trial suggests. Patients taking a 10-milligram (mg) daily dose of pharmaceutical grade cannabidiol (CBD) experienced nearly as great a reduction in seizures as patients […]

Cannabidiol (CBD), a compound derived from the cannabis plant that does not produce a “high” and has been an increasing focus of medical research, was shown in a new large-scale, randomized, controlled trial to significantly reduce the number of dangerous seizures in patients with a severe form of epilepsy called Lennox–Gastaut syndrome. In the new […]

Local Headlines Copyright 2018 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. Copyright 2018 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. “);b.ajax({type:”GET”,url:c}).done(function(h){var i=b(h);d.empty();d.append(i)}).fail(function(){d.append(“ Oops. Something went wrong. Please wait a… read more at: http://www.nbc4i.com/news/local-news/cannabis-derived-treatment-shows-significant-seizure-reduction-in-nationwide-children-s-study/1183520100

By Brett Taylor and Amy Alderfer May 9, 2018, 1:26 PM EDT Law360 (May 9, 2018, 1:26 PM EDT) — Legalization of marijuana has been a popular idea in recent years, with 30 states and the District of Columbia having laws that legalize marijuana in some form. However, under federal law, marijuana is a Schedule […]

Insys Therapeutics’ Phase 2 trial to evaluate the safety and effectiveness of its cannabidiol (CBD) oral solution in pediatric patients with Prader-Willi syndrome (PWS) will soon begin recruiting participants. More information about the study and dates of enrollment will be announced on the clinical trial’s official webpage, found here (NCT02844933). The Insys announcement also recognizes May as PWS Awareness […]